mRNA VACCINE DEVELOPMENT

DEVELOPMENT

PRECLINCAL

PHASE 1

PHASE 2

PHASE 3

INDICATION
mRNA Universal Coronavirus Vaccine (UCV)

GLOBAL PUBLIC HEALTH IMPACT
Prophylactic mRNA Vaccine. Therapeutic mRNA Vaccine (long-covid)

PARTNERS / SUPPORTERS
mRNA UCV Consortium

COMMERCIAL
Norvax UK

LICENSING
Vaxcomm

mRNA-UCV Vaccine

DEVELOPMENT

INDICATION
mRNA Universal Coronavirus Vaccine (UCV)

TECHNOLOGY
Prophylactic mRNA Vaccine. Therapeutic mRNA Vaccine (long-covid)

PARTNERS / SUPPORTERS
mRNA UCV Consortium

COMMERCIAL
Norvax UK

LICENSING
Vaxcomm

GMP PRODUCT DEVELOPMENT

DEVELOPMENT

STAGE 1

STAGE 2

STAGE 3

PRODUCTION

APPLICATION
mRNA Vaccines for Global Public Health

INNOVATION
mRNA Vaccine Manufacturing CDMO

PARTNERS / SUPPORTERS
mRNA UCV Consortium / Innovation Norway

COMMERCIAL
Norvax AS

LICENSING
Vaxcomm

Norsk Vaksinefabrikk

STAGE 1

APPLICATION
mRNA Vaccines for Global Public Health

INNOVATION
mRNA Vaccine Manufacturing CDMO.

PARTNERS / SUPPORTERS
SINTEF /The Research Council of Norway

COMMERCIAL
Norvax UK

LICENSING
Vaxcomm

DEVELOPMENT

STAGE 1

STAGE 2

STAGE 3

PRODUCTION

APPLICATION
mRNA Vaccine Delivery & Lyophilization

INNOVATION
Thermostable Lipid Nanoparticle Formulation(s)

PARTNERS / SUPPORTERS
SINTEF /The Research Council of Norway

COMMERCIAL
Norvax AS

LICENSING
Vaxcomm

NORVAX-LNP

STAGE 1

APPLICATION
mRNA Vaccine Delivery & Lyophilization

INNOVATION
Thermostable Lipid Nanoparticle Formulation(s).

PARTNERS / SUPPORTERS
SINTEF /The Research Council of Norway

COMMERCIAL
Norvax AS

LICENSING
Vaxcomm

mRNA Vaccine Platform

DEVELOPMENT

STAGE 1

STAGE 2

STAGE 3

PRODUCTION

APPLICATION
mRNA Vaccine Innovation & Manufacturing

INNOVATION
End-to-End cGMP Infrastructure for mRNA Vaccines and LNPs

PARTNERS / SUPPORTERS
mRNA UCV Consortium

COMMERCIAL
Norvax AS

LICENSING
Vaxcomm

mRNA Vaccine Platform

STAGE 1

APPLICATION
mRNA Vaccine Innovation & Manufacturing

INNOVATION
End-to-End cGMP Infrastructure for mRNA Vaccines and LNPs.

PARTNERS / SUPPORTERS
mRNA UCV Consortium

COMMERCIAL
Norvax AS

LICENSING
Vaxcomm

NORVAX-IDS

DEVELOPMENT

STAGE 1

STAGE 2

STAGE 3

PRODUCTION

APPLICATION
mRNA Immunogen Design & Selection Management System

INNOVATION
High Securty Jamstack Headless CMS. RNAseq Checks. AI Analytics.

PARTNERS / SUPPORTERS
mRNA UCV Consortium

COMMERCIAL
Norvax AS

LICENSING
Vaxcomm

NORVAX-IDS

DEPLOYED

APPLICATION
mRNA Immunogen Design & Selection Management System

INNOVATION
High Securty Jamstack Headless CMS. RNAseq Checks. AI Analytics.

PARTNERS / SUPPORTERS
mRNA UCV Consortium

COMMERCIAL
Norvax AS

LICENSING
Vaxcomm

NORVAX-OPS

DEVELOPMENT

STAGE 1

STAGE 2

STAGE 3

PRODUCTION

APPLICATION
mRNA Vaccine Manufacturing Platform

INNOVATION
Jamstack Headless CMS Apps: QMS. ERP. OPS. Clinical. Projects.

PARTNERS / SUPPORTERS
mRNA UCV Consortium

COMMERCIAL
Norvax AS

LICENSING
Vaxcomm

NORVAX-OPS

DEPLOYED

APPLICATION
mRNA Vaccine Manufacturing Platform

INNOVATION
Jamstack Headless CMS Apps: QMS. ERP. OPS. Clinical. Projects.

PARTNERS / SUPPORTERS
mRNA UCV Consortium

COMMERCIAL
Norvax AS

LICENSING
Vaxcomm

NORVAX-PCTS

DEVELOPMENT

STAGE 1

STAGE 2

STAGE 3

PRODUCTION

APPLICATION
mRNA IDS Preclinical Translational Model

INNOVATION
Precision-Cut Tissue Slices (PCTS) Preclin Data Innovation

PARTNERS / SUPPORTERS
mRNA UCV Consortium

COMMERCIAL
Norvax AS

LICENSING
Vaxcomm

NORVAX-PCTS

DEVELOPMENT

APPLICATION
mRNA IDS Preclinical Translational Model

INNOVATION
Precision-Cut Tissue Slices (PCTS) Preclin Data Innovation.

PARTNERS / SUPPORTERS
mRNA UCV Consortium

COMMERCIAL
Norvax AS

LICENSING
Vaxcomm

NORVAX-AI

DEVELOPMENT

STAGE 1

STAGE 2

STAGE 3

PRODUCTION

APPLICATION
mRNA Deep Learning AI Preclinical Translational Process

INNOVATION
In Silico Immunogen Design and Selection (IDS) with Deep Learning Artificial Intelligence (AI)

PARTNERS / SUPPORTERS
mRNA UCV Consortium

COMMERCIAL
Norvax AS

LICENSING
Vaxcomm

NORVAX-AI

DEVELOPMENT

APPLICATION
mRNA IDS Preclinical Translational Model

INNOVATION
in silico immunogen design and selection (IDS) with Deep Learning Artificial Intelligence (AI)

PARTNERS / SUPPORTERS
mRNA UCV Consortium

COMMERCIAL
Norvax AS

LICENSING
Vaxcomm

COVIPS

DEVELOPMENT

STAGE 1

STAGE 2

STAGE 3

PRODUCTION

APPLICATION
Covid Open Vaccine International Platform for Safety (COVIPS)

INNOVATION
Rapid & Cost-effective Clinical Trials for Safety & Efficacy Data

PARTNERS / SUPPORTERS
mRNA UCV Consortium

COMMERCIAL
Norvax AS

LICENSING
Vaxcomm

COVIPS

DEVELOPMENT

APPLICATION
Covid Open Vaccine International Platform for Safety (COVIPS)

INNOVATION
Rapid & Cost-effective Clinical Trials for Safety & Efficacy Data.

PARTNERS / SUPPORTERS
mRNA UCV Consortium

COMMERCIAL
Norvax UK

LICENSING
Vaxcomm

COVIPS Biobank

DEVELOPMENT

STAGE 1

STAGE 2

STAGE 3

PRODUCTION

APPLICATION
Covid-19 Biobank Preclinical. Phase I. Phase II. Phase III.

INNOVATION
Open Biobank Data and Global Resource for R&D Impact

PARTNERS / SUPPORTERS
mRNA UCV Consortium

COMMERCIAL
Norvax AS

LICENSING
Vaxcomm

COVIPS Biobank

DEVELOPMENT

APPLICATION
Covid-19 Biobank Preclinical. Phase I. Phase II. Phase III.

INNOVATION
Rapid & Cost-effective Clinical Trials for Safety & Efficacy Data.

PARTNERS / SUPPORTERS
mRNA UCV Consortium

COMMERCIAL
Norvax UK

LICENSING
Vaxcomm

DIAGNOSTIC PRODUCTS

Norvax FastTest COVID-19

DEVELOPMENT

STAGE 1

STAGE 2

STAGE 3

PRODUCTION

APPLICATION
SARS-CoV-2 & Variants of Concern: Alpha. Beta. Gamma. Delta.

INNOVATION
Lateral Flow Diagnistic Antigen Test

PARTNERS / SUPPORTERS
GOV UK Dept.of Health and Social Care (DHSC)

COMMERCIAL
Norvax UK

LICENSING
Vaxcomm

Norvax FastTest COVID-19

FUNCTIONAL

APPLICATION
SARS-CoV-2 & Variants of Concern: Alpha. Beta. Gamma. Delta.

INNOVATION
Lateral Flow Diagnistic Antigen Test.

PARTNERS / SUPPORTERS
GOV UK Dept.of Health and Social Care (DHSC)

COMMERCIAL
Norvax UK

LICENSING
Vaxcomm

CHEC Mobile App

DEVELOPMENT

STAGE 1

STAGE 2

STAGE 3

PRODUCTION

APPLICATION
Covid Health Examined Certificate (CHEC)

INNOVATION
Immutable Data Recording of Test Results on Distributed Ledger

PARTNERS / SUPPORTERS
GOV UK Dept.of Health and Social Care (DHSC)

COMMERCIAL
Norvax UK

LICENSING
Vaxcomm

CHEC Mobile App

DEPLOYED

APPLICATION
Covid Health Examined Certificate (CHEC).

INNOVATION
Immutable Data Recording of Test Results on Distributed Ledger.

PARTNERS / SUPPORTERS
GOV UK Dept.of Health and Social Care (DHSC)

COMMERCIAL
Norvax UK

LICENSING
Vaxcomm

Norvax FastTest bTB

DEVELOPMENT

STAGE 1

STAGE 2

STAGE 3

PRODUCTION

APPLICATION
Bovine Tuberculosis (bTB). Mycobacterium bovis.

INNOVATION
Lateral Flow Diagnistic Blood Test in harmony with Vaccine

PARTNERS / SUPPORTERS
The Royal Veterinary College and UC Davis

COMMERCIAL
Norvax UK

LICENSING
Vaxcomm

Norvax FastTest bTB

DEVELOPMENT

APPLICATION
Bovine Tuberculosis (bTB). Mycobacterium bovis.

INNOVATION
Lateral Flow Diagnistic Blood Test in harmony with Vaccine.

PARTNERS / SUPPORTERS
The Royal Veterinary College and UC Davis

COMMERCIAL
Norvax UK

LICENSING
Vaxcomm

Norvax FastTest TB

DEVELOPMENT

STAGE 1

STAGE 2

STAGE 3

PRODUCTION

APPLICATION
Tuberculosis (TB). Mycobacterium tuberculosis.

INNOVATION
Lateral Flow Diagnistic Blood Test in harmony with Vaccine

PARTNERS / SUPPORTERS
mRNA UCV Consortium

COMMERCIAL
Norvax UK

LICENSING
Vaxcomm

Norvax FastTest TB

DEVELOPMENT

APPLICATION
Tuberculosis (TB). Mycobacterium tuberculosis.

INNOVATION
Lateral Flow Diagnistic Blood Test in harmony with Vaccine.

PARTNERS / SUPPORTERS
mRNA UCV Consortium

COMMERCIAL
Norvax UK

LICENSING
Vaxcomm

IMMUTABLE ASSET REGISTRY

DEVELOPMENT

STAGE 1

STAGE 2

STAGE 3

PRODUCTION

APPLICATION
Issuance of Shares and Bonds to Shareholder Registry

INNOVATION
Distributed Ledger Tech (DLT) Immutable Asset Recording and Transfer

PARTNERS / SUPPORTERS
By Invitation Only. Not an Offer to Invest.

COMMERCIAL
ECAM Mgmt.

LICENSING
DLT/Open

MY ECAM (for Norvax)

DEVELOPMENT

APPLICATION
Issuance of Shares and Bonds to Shareholder Registry.

INNOVATION
Distributed Ledger Tech (DLT) Immutable Asset Recording and Transfer.

PARTNERS / SUPPORTERS
By Invitation Only. Not an Offer to Invest.

COMMERCIAL
ECAM Mgmt.

LICENSING
DLT/Open